| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.021 | 0.7 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.022 | 0.7 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.7 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |